ETR:SRT - Sartorius Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started €129.00 -3.00 (-2.27 %) (As of 03/25/2019 07:33 AM ET)Previous Close€132.00Today's Range€129.00 - €130.5052-Week Range€90.40 - €140.50Volume178 shsAverage VolumeN/AMarket Capitalization$8.82 billionP/E Ratio62.41Dividend Yield0.48%BetaN/A ProfileDiscussionAnalyst RatingsChartHeadlinesOptions Chain Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Sartorius Aktiengesellschaft provides pharmaceutical and laboratory equipment worldwide. The company operates through two divisions, Bioprocess Solutions, and Lab Products & Services. The Bioprocess Solutions division offers products, technologies, and services ranging from fermentation, cell cultivation, filtration, and purification to media storage and transportation for the biopharmaceutical industry. It provides filtration and purification, sterile filtration, virus filtration, crossflow filtration, harvesting, prefiltration, membrane chromatography, air/gas filtration, integrity testing, and OEM membranes; process analyzers, process control tools, microbiology products, and chemometric software; single-use bioprocess bags, containers, mixing systems, aseptic transfer systems, freeze and thaw systems, aseptic sampling and bottle closure systems, and tubing dis-/connectors; media USP and buffers DSP; bioreactors/fermentors; and FlexAct, a system that enables to custom-configure single-use solutions for entire biomanufacturing steps. The Lab Products & Services division provides laboratory instruments, such as lab balances, pipettes, and laboratory water purification systems; and consumables, including laboratory filters and pipette tips. Its products include OEM weigh cells, mass comparators and metrology, weights/weight sets, and paint mixing solutions; microbiology products and moisture analyzers; lab water systems; pipette tips and pipette calibration; bioreactors/fermentors and centrifuges; and filtration, ultrafiltration, membrane chromatography products, virus purification kits, diagnostic membranes and arrays, and blotting membranes, as well as aseptic bottle closure systems. The company also offers instrument, validation, and training services. It serves biopharmaceutical and pharmaceutical, public research institutes, and chemical and food sectors. The company was founded in 1870 and is headquartered in Goettingen, Germany. Receive SRT News and Ratings via Email Sign-up to receive the latest news and ratings for SRT and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange ETR Industry Diagnostics & Research Sub-IndustryN/A SectorMedical Current SymbolETR:SRT Previous Symbol CUSIPN/A CIKN/A Webwww.sartorius.com Phone49 551 308 0Debt Debt-to-Equity Ratio103.21 Current Ratio1.57 Quick Ratio0.81Price-To-Earnings Trailing P/E Ratio62.41 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$1.57 billion Price / Sales5.63 Cash Flow€0.96 per share Price / Cash Flow134.52 Book Value€10.83 per share Price / Book11.91Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares68,388,304Market Cap$8.82 billion Next Earnings DateN/A OptionableOptionable Sartorius (ETR:SRT) Frequently Asked Questions What is Sartorius' stock symbol? Sartorius trades on the ETR under the ticker symbol "SRT." What price target have analysts set for SRT? 8 analysts have issued twelve-month price objectives for Sartorius' shares. Their predictions range from €93.00 to €142.00. On average, they expect Sartorius' share price to reach €114.88 in the next twelve months. This suggests that the stock has a possible downside of 10.9%. View Analyst Price Targets for Sartorius. What is the consensus analysts' recommendation for Sartorius? 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sartorius in the last year. There are currently 4 sell ratings and 4 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Sartorius. Has Sartorius been receiving favorable news coverage? News coverage about SRT stock has trended somewhat negative this week, InfoTrie reports. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Sartorius earned a news sentiment score of -1.1 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the near term. Who are some of Sartorius' key competitors? Some companies that are related to Sartorius include Carl Zeiss Meditec (AFX), NationalResearchCorp . (NRC), Senseonics (SENS), Senseonics (SENS), Integral Diagnostics (IDX), Akumin (AKU), Palatin Technologies (PTN), MaxCyte (MXCT), Profound Medical (PRN), Renalytix Ai (RENX), Yourgene Health (YGEN), Oncimmune (ONC), Lexagene (LXG), Sernova (SVA) and GeneNews (GEN). What other stocks do shareholders of Sartorius own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sartorius investors own include Micron Technology (MU), Constellation Brands (STZ), Select Energy Services (WTTR), Mid-America Apartment Communities (MAA), Align Technology (ALGN), AAR (AIR), Lendlease Group (LLC), Cytokinetics (CYTK), General Electric (GE) and United States Brent Oil Fund (BNO). Who are Sartorius' key executives? Sartorius' management team includes the folowing people: Dr. Joachim Kreuzburg, Chairman of Exec. Board & CEO (Age 54)Mr. Rainer Lehmann, CFO & Member of Exec. Board (Age 43)Ms. Petra Kirchhoff, VP of Corp. Communications & Investor Relations and Member of Supervisory Board (Age 50)Mr. Gerry Mackay, Head of Lab Products & Services Division & Member of Exec. Board (Age 56)Dr. René Fáber, Head of Bioprocess Solutions Division & Member of Exec. Board (Age 43) What is Sartorius' stock price today? One share of SRT stock can currently be purchased for approximately €129.00. How big of a company is Sartorius? Sartorius has a market capitalization of $8.82 billion and generates $1.57 billion in revenue each year. What is Sartorius' official website? The official website for Sartorius is http://www.sartorius.com. How can I contact Sartorius? The company can be reached via phone at 49 551 308 0. MarketBeat Community Rating for Sartorius (ETR SRT)Community Ranking: 1.9 out of 5 ()Outperform Votes: 24 (Vote Outperform)Underperform Votes: 40 (Vote Underperform)Total Votes: 64MarketBeat's community ratings are surveys of what our community members think about Sartorius and other stocks. Vote "Outperform" if you believe SRT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SRT will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/25/2019 by MarketBeat.com StaffFeatured Article: How does a 12b-1 fee affect fund performance?